NCT07100756

Brief Summary

The aim of this study is to evaluate clinical effectiveness and cost-effectiveness after implementing a medically approved and commercially available AI support system for opportunistic vertebral fracture screening in CT examinations within an adapted fracture care pathway (integrated care process) in clinical routine. Data will be compared to historical data (same period the previous year). The main question it aims to answer is: Does opportunistic AI-supported vertebral fracture screening in CT examinations integrated to a fracture care pathway increase the numbers of diagnosed vertebral fractures compared to usual care? CT scans in the clinical routine care will be opportunistically screened for vertebral fractures by the AI for 4 months. All positive findings will be confirmed by a radiologist and triaged by the FLS (Fracture Liaison Service).

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10,500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 20, 2023

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 19, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 14, 2025

Completed
20 days until next milestone

First Posted

Study publicly available on registry

August 3, 2025

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 19, 2026

Completed
Last Updated

August 3, 2025

Status Verified

July 1, 2025

Enrollment Period

1.6 years

First QC Date

July 14, 2025

Last Update Submit

July 27, 2025

Conditions

Keywords

vertebral fractureosteoporosiscomputed tomographyAI

Outcome Measures

Primary Outcomes (1)

  • Vertebral fractures (ICD coded)

    Numbers of ICD-coded vertebral fractures within 3 months from the CT scan.

    Within 3 months from CT scan

Secondary Outcomes (4)

  • Reported vertebral fractures (radiology report)

    Within 2 months after the CT scan

  • DXA screened patients

    Within 12 months after the CT scan

  • Medical treatment (anti-osteoporotic)

    Within 12 months after the CT scan

  • Cost-effectiveness

    Two time frames: Within 12 months after the CT scan and long-term using a decision-analytic model to assess outcome in 10 years

Other Outcomes (6)

  • Performance of AI

    Baseline

  • Vertebral fractures (radiologist confirmed)

    Baseline

  • New or worsened vertebral fractures

    Baseline

  • +3 more other outcomes

Study Arms (2)

Usual care

The control cohort (usual care), representing routine care, consists of historical data from the corresponding period one year prior to the implementation of AI-based screening. In standard clinical practice, radiologists are expected to report incidental findings, including vertebral fractures. It is then the responsibility of the referring physician to act upon such findings and ensure appropriate follow-up. This includes initiating further investigation and treatment for osteoporosis in accordance with established clinical guidelines.

AI screening aligned with FLS

In the AI cohort, an algorithm was integrated into the clinical workflow to automatically analyze CT scans of the thoracic and lumbar spine for vertebral fractures as part of opportunistic screening. Positive findings were automatically listed in the radiology PACS and subsequently reviewed and confirmed by dedicated radiologists. Confirmed fractures were referred to the Fracture Liaison Service (FLS), where a coordinator and osteoporosis specialist managed further care. Based on clinical assessment, a referral was issued to primary care, which remained responsible for continued investigation and treatment according to standard regional practice.

Device: AI vertebral fracture diagnostics (Flamingo)

Interventions

The AI (name: Flamingo from Image Biopsy Lab, IBL, Vienna, Austria) screens thoracic and abdominal CT scans for vertebral fractures.

AI screening aligned with FLS

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients \>= 50 years, undergoing a clinical thoracic or abdominal CT-scan in at Linköping University Hospital

You may qualify if:

  • abdominal or thoracic CT scans performed in clinical routine from patients living in the catchment area
  • women and men
  • age 50 or higher

You may not qualify if:

  • CT scans using spine-only protocol with exclusively skeletal queries

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Linköping University Hospital

Linköping, Sweden

Location

MeSH Terms

Conditions

Spinal FracturesOsteoporosis

Condition Hierarchy (Ancestors)

Spinal InjuriesBack InjuriesWounds and InjuriesFractures, BoneBone Diseases, MetabolicBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Anna Spångeus, Ass Prof MD

    Linköpings University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc Prof MD

Study Record Dates

First Submitted

July 14, 2025

First Posted

August 3, 2025

Study Start

October 20, 2023

Primary Completion

May 19, 2025

Study Completion

February 19, 2026

Last Updated

August 3, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations